Top
What's new?
DWTI news
About DWTI
CEO Message
Vision
Company Overview
Business Overview
Passion of the Founder
Research&Development
R&D Overview
Product Pipeline
Glossary of technical terms
Scientific Advisory Board
IR
Top Message
Fianacial Highlights
Shareholders' Information
inquiries
Stock Quote
Disclaimer
About this site
Site policy
Privacy policy
Access
Site map
Contact
synthesize new substances from seed compounds to discover new drug candidates by screening effective compounds against target diseases.
search for a drug targeted proteins and reveal functional mechanism
grant patents for new developed compounds.
license out a granted compound to a pharmaceutical company before clinical stage.
achieve solid clinical result by sharing drug development know-how, under partnership with license-own pharmaceutical company.
incubate in-license products to clinical stage.
Front Money
Lump-sum payment received at the completion of licensing out contract.
Milestone
Lump-sum payment received at each juncture of clinical development progress .
Research and guidance fee
receipt for elucidation of the active mechanism and clinical development cooperation .
Royalty
receipt for constant percentage of the drug sales gained after the release to the market.
Site policy
|
Privacy policy
|
Access
|
Site map
|
Contact